Danguole Altman

Danguole Altman possesses extensive leadership experience in the healthcare and life sciences sectors. Currently serving as President and CEO of Cx Precision Medicine, Inc. since December 2019, Danguole focuses on utilizing AI/ML for diagnosing neurodegenerative diseases. As a Partner at Newport LLC, Danguole collaborates with CEOs and Boards to enhance middle market companies, particularly in life sciences and healthcare services. Previously, Danguole co-founded Vapogenix Inc., leading the company through successful drug development and raising over $18M. Earlier career highlights include founding FemPartners, Inc. and serving as CEO of Obstetrical and Gynecological Associates, PA, as well as impactful roles at HCA Healthcare, Kelsey-Seybold Clinic, and McKinsey and Company. Educational credentials include an AB in Economics from Harvard University and an MBA from Yale School of Management.